Crossmark

Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma

Crossref DOI link: https://doi.org/10.1007/s00262-019-02303-1

Published Online: 2019-01-21

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abu-Sbeih, Hamzah

Ali, Faisal S.

Qiao, Wei

Lu, Yang

Patel, Sapna

Diab, Adi

Wang, Yinghong https://orcid.org/0000-0002-5148-6130
License Information

Text and Data Mining valid from 2019-01-21
More Information

Article History

Received: 27 September 2018

Accepted: 12 January 2019

First Online: 21 January 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interests.

: This retrospective, single-center study was approved by the Institutional Review Board at MD Anderson Cancer Center. Approval number: PA18-0472.

: This study was granted waiver of consent.